Business

LUNAI BIOWORKS, INC. ANNOUNCES REVERSE STOCK SPLIT

Lunai Bioworks, Inc. (Nasdaq: LNAI) (the "Company") today announced that it will effect a reverse stock split of its issued and outstanding common stock, par value $0.0001 per share (the "Common Stock"), at a ratio of 1-for-8 (the "Reverse Stock Split"). The Reverse Stock Split is expected to become effective at 12:01 a.m. Eastern Time on May 22, 2026, and the Company's Common Stock is expected to begin trading on a split-adjusted basis on The Nasdaq Capital Market at the opening of trading on M

articleLunai Bioworks Inc.May 20, 20265/company/lunai-bioworks-inc/news/lunai-bioworks-inc-announces-reverse-stock-split
LUNAI BIOWORKS, INC. ANNOUNCES REVERSE STOCK SPLIT

About this update from Lunai Bioworks Inc.

[{"type":"text","content":"SACRAMENTO, Calif., May 20, 2026 /PRNewswire/ -- Lunai Bioworks, Inc. (Nasdaq: LNAI) (the "Company") today announced that it will effect a reverse stock split of its issued and outstanding common stock, par value $0.0001 per share (the "Common Stock"), at a ratio of 1-for-8 (the "Reverse Stock Split"). The Reverse Stock Split is expected to become effective at 12:01 a.m. Eastern Time on May 22, 2026, and the Company's Common Stock is expected to begin trading on a split-adjusted basis on The Nasdaq Capital Market at the opening of trading on May 22, 2026, under the existing trading symbol "LNAI."","length":652,"tagName":"p"},{"type":"image","alt":"Lunai Bioworks Inc. (PRNewsfoto/Lunai Bioworks Inc.)","displaySize":"","headline":null,"caption":"Lunai Bioworks Inc. (PRNewsfoto/Lunai Bioworks Inc.)","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":123,"url":"https://media.zenfs.com/en/prnewswire.com/e1394d131f94f2906bb3fbc63140be9f"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/q9GRWtzRx._Bb48NHqaSiQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTIxNw--/https://media.zenfs.com/en/prnewswire.com/e1394d131f94f2906bb3fbc63140be9f","width":400,"height":123},"resize_sm":{"url":"https://s.yimg.com/ny/api/res/1.2/Bn6fT.eLT2mTacy84uu7Kg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTY0MDtoPTE5Nw--/https://media.zenfs.com/en/prnewswire.com/e1394d131f94f2906bb3fbc63140be9f","width":400,"height":123}},"href":"https://mma.prnewswire.com/media/2814530/Lunai_Logo.html","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":"The Company's Common Stock will trade under a new CUSIP number, 29350E302 following the effectiveness of the Reverse Stock Split.","length":133,"tagName":"p"},{"type":"text","content":"At the Company's Special Meeting of Stockholders held on May 8, 2026, the Company's stockholders approved a proposal authorizing the Company's Board of Directors to amend the Company's Certificate of Incorporation to effect a reverse stock split of the Common Stock at a ratio in the range of 1-for-3 to 1-for-30, inclusive, with the exact ratio to be determined by the Board in its sole discretion and publicly announced prior to the effective time of the Reverse Stock Split. The Board of Directors subsequently approved the final 1-for-8 Reverse Stock Split ra...

More updates from Lunai Bioworks Inc.

reverse stock splitthe CompanyNasdaqcommon stockoutstanding sharefractional sharesCompany